Florida-based Catalyst Pharmaceuticals is attempting to show in court that the price of a newly approved treatment for a rare autoimmune disease and pressure from U.S. Sen. Bernie Sanders lead to the approval of a rival treatment.
Healthcare Agency Roundtable 2015
21st Century Cures Act, ACA, Affordable Care Act, Approvals, Biosimilars, December 2015, Digital, Digital Marketing, DTC, FDA, FDA/Regulatory, Generics, Healthcare, Healthcare Communications Agencies, Healthcare Physicians, Healthcare Practitioners, Healthcare Providers, Healthcare/Medicare/Medicaid, Issue Archives, Launches, Legislation, Marketing & Advertising, New Molecular Entities, Patient Outcomes, Politics, Presidential Candidates, Price Gouging, Price Hikes, Pricing, Product Launches, Retail Pharmaceuticals, Special Reports, Technology, WearablesExecutives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.
The debate in Washington over drug pricing is getting louder and nastier, and drug marketing is getting caught in the crossfire.